litlas
ログインアカウント作成

William T. Cefalu

1983–2025 年に発表

98
論文数
26,126
被引用数
81
h 指数
97
i10 指数

被引用数

William T. Cefalu の年別被引用数1983 年: 被引用 3 件1984 年: 被引用 2 件1985 年: 被引用 3 件1986 年: 被引用 5 件1987 年: 被引用 3 件1988 年: 被引用 6 件1989 年: 被引用 6 件1990 年: 被引用 11 件1991 年: 被引用 7 件1992 年: 被引用 7 件1993 年: 被引用 4 件1994 年: 被引用 7 件1995 年: 被引用 4 件1996 年: 被引用 4 件1997 年: 被引用 14 件1998 年: 被引用 15 件1999 年: 被引用 25 件2000 年: 被引用 28 件2001 年: 被引用 33 件2002 年: 被引用 58 件2003 年: 被引用 58 件2004 年: 被引用 54 件2005 年: 被引用 63 件2006 年: 被引用 59 件2007 年: 被引用 69 件2008 年: 被引用 55 件2009 年: 被引用 59 件2010 年: 被引用 85 件2011 年: 被引用 102 件2012 年: 被引用 127 件2013 年: 被引用 156 件2014 年: 被引用 230 件2015 年: 被引用 236 件2016 年: 被引用 248 件2017 年: 被引用 252 件2018 年: 被引用 238 件2019 年: 被引用 924 件2020 年: 被引用 1,222 件2021 年: 被引用 1,114 件2022 年: 被引用 941 件2023 年: 被引用 736 件2024 年: 被引用 1,049 件2025 年: 被引用 470 件2026 年: 被引用 22 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,096 件、この内訳の 23.7%中国: 引用元論文 1,183 件、この内訳の 9%イギリス: 引用元論文 892 件、この内訳の 6.8%イタリア: 引用元論文 640 件、この内訳の 4.9%カナダ: 引用元論文 486 件、この内訳の 3.7%ドイツ: 引用元論文 483 件、この内訳の 3.7%オーストラリア: 引用元論文 435 件、この内訳の 3.3%スペイン: 引用元論文 395 件、この内訳の 3%インド: 引用元論文 346 件、この内訳の 2.7%オランダ: 引用元論文 317 件、この内訳の 2.4%フランス: 引用元論文 291 件、この内訳の 2.2%デンマーク: 引用元論文 282 件、この内訳の 2.2%
0%23.7%その他 32.4%

機関

分野

  • Medicine70.4%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Neuroscience2.8%
  • Nursing2.5%
  • Agricultural and Biological Sciences2.4%
  • Environmental Science1.1%
  • その他4.3%

トピック

  • Diabetes Management and Research7.8%
  • Diabetes Treatment and Management6.6%
  • Diet and metabolism studies5.9%
  • Pancreatic function and diabetes4.9%
  • Gut microbiota and health3.6%
  • Dietary Effects on Health3.3%
  • その他67.9%

共著者

全論文

検索で開く
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    著者: Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 被引用: 3,797

  2. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

    著者: Zhan‐Guo Gao, Jun Yin, Jin Zhang, Robert E. Ward, Roy J. Martin, Michael Lefevre, William T. Cefalu, Jianping Ye - Diabetes 2009 被引用: 2,189

  3. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes

    著者: Elizabeth F. Sutton, Robbie A. Beyl, Kate Early, William T. Cefalu, Éric Ravussin, Courtney M. Peterson - Cell Metabolism 2018 被引用: 1,461

  4. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

    著者: Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, George Grunberger, David B. Sacks, Aaron J. Kowalski, Adam S. Brown, Lutz Heinemann, Grazia Aleppo, Donna B. Ryan, Tonya D. Riddlesworth, William T. Cefalu - Diabetes Care 2018 被引用: 662

  5. Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    著者: Wendy K. Chung, Karel Erion, José C. Florez, Andrew T. Hattersley, Marie‐France Hivert, Christine G. Lee, Mark I. McCarthy, John J. Nolan, Jill M. Norris, Ewan R. Pearson, Louis H. Philipson, Allison T. McElvaine, William T. Cefalu, Stephen S. Rich, Paul W. Franks - Diabetes Care 2020 被引用: 392

  6. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps

    著者: Charmaine S. Tam, Wenting Xie, William D. Johnson, William T. Cefalu, Leanne M. Redman, Éric Ravussin - Diabetes Care 2012 被引用: 364

  7. An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus

    著者: Daniel S. Hsia, Owen Grove, William T. Cefalu - Current Opinion in Endocrinology Diabetes and Obesity 2016 被引用: 499

  8. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    著者: Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 被引用: 971

  9. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

    著者: William T. Cefalu, Lawrence A. Leiter, Kun‐Ho Yoon, Pablo Arias, Leo Niskanen, John Xie, Dainius Balis, William Canovatchel, Gary Meininger - The Lancet 2013 被引用: 724

  10. Adipocyte iron regulates adiponectin and insulin sensitivity

    著者: J. Scott Gabrielsen, Yan Gao, Judith Simcox, Jingyu Huang, David Thorup, Deborah L. Jones, Robert C. Cooksey, David A. Gabrielsen, Ted D. Adams, Steven C. Hunt, Paul N. Hopkins, William T. Cefalu, Donald A. McClain - Journal of Clinical Investigation 2012 被引用: 330

  11. Diabetes and Aging: Unique Considerations and Goals of Care

    著者: Rita R. Kalyani, Sherita Hill Golden, William T. Cefalu - Diabetes Care 2017 被引用: 229

  12. Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans

    著者: Richard V. Clark, Ann C. Walker, Robin O'Connor‐Semmes, Michael S. Leonard, Ram R. Miller, Stephen A. Stimpson, Scott Turner, Éric Ravussin, William T. Cefalu, Marc K. Hellerstein, William J. Evans - Journal of Applied Physiology 2014 被引用: 174

  13. How Do We Define Cure of Diabetes?

    著者: John B. Buse, Sonia Caprio, William T. Cefalu, Antonio Ceriello, Stefano Del Prato, Silvio E. Inzucchi, Sue McLaughlin, Gordon L. Phillips, R. P. Robertson, Francesco Rubino, Richard Kahn, M. Sue Kirkman - Diabetes Care 2009 被引用: 997

  14. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum

    著者: William T. Cefalu, Sanjay Kaul, Hertzel C. Gerstein, Rury R. Holman, Bernard Zinman, Jay S. Skyler, Jennifer B. Green, John B. Buse, Silvio E. Inzucchi, Lawrence A. Leiter, Itamar Raz, Julio Rosenstock, Matthew C. Riddle - Diabetes Care 2017 被引用: 369

  15. Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

    著者: William T. Cefalu, Lawrence A. Leiter, Tjerk W.A. de Bruin, Ingrid Gause‐Nilsson, Jennifer Sugg, Shamik Parikh - Diabetes Care 2015 被引用: 184

  16. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

    著者: Matthew C. Riddle, William T. Cefalu, Philip Evans, Hertzel C. Gerstein, Michael A. Nauck, William Oh, Amy E. Rothberg, Carel W. le Roux, Francesco Rubino, Philip R. Schauer, Roy Taylor, Douglas Twenefour - Diabetes Care 2021 被引用: 420

  17. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum

    著者: William T. Cefalu, George A. Bray, Philip Home, W. Timothy Garvey, Samuel Klein, F. Xavier Pi‐Sunyer, Frank B. Hu, Itamar Raz, Luc Van Gaal, Bruce M. Wolfe, Donna H. Ryan - Diabetes Care 2015 被引用: 237

  18. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels

    著者: Stephen D. Anton, Corby K. Martin, Hongmei Han, Sandra M. Coulon, William T. Cefalu, Paula J. Geiselman, Donald A. Williamson - Appetite 2010 被引用: 445

  19. Bioactives in Blueberries Improve Insulin Sensitivity in Obese, Insulin-Resistant Men and Women1–4

    著者: April J. Stull, Katherine C. Cash, William D. Johnson, Catherine M. Champagne, William T. Cefalu - Journal of Nutrition 2010 被引用: 394

  20. Insulin Access and Affordability Working Group: Conclusions and Recommendations

    著者: William T. Cefalu, Daniel Dawes, Gina Gavlak, Dana P. Goldman, William H. Herman, Karen Van Nuys, Alvin C. Powers, Simeon I. Taylor, Alan L. Yatvin, on behalf of the Insulin Access and Affordability Working Group - Diabetes Care 2018 被引用: 257

  21. Blueberries Improve Endothelial Function, but Not Blood Pressure, in Adults with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    著者: April J. Stull, Katherine C. Cash, Catherine M. Champagne, Alok Gupta, Raymond C. Boston, Robbie A. Beyl, William D. Johnson, William T. Cefalu - Nutrients 2015 被引用: 165

  22. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

    著者: Kaj Stenlöf, William T. Cefalu, Kyung‐Ah Kim, Maria Alba, Keith Usiskin, C. Tong, William Canovatchel, Gary Meininger - Diabetes Obesity and Metabolism 2012 被引用: 611

  23. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

    著者: Sandeep R. Das, Brendan M. Everett, Kim K. Birtcher, Jenifer M. Brown, William T. Cefalu, James L. Januzzi, Rita R. Kalyani, Mikhail Kosiborod, Melissa Magwire, Pamela B. Morris, Laurence Sperling - Journal of the American College of Cardiology 2018 被引用: 310

  24. Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

    著者: Arthur Sands, Brian Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W. Bode, Satish K. Garg, John B. Buse, Phillip Banks, Rubina A. Heptulla, Marc Rendell, William T. Cefalu, Paul Strumph - Diabetes Care 2015 被引用: 216